Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 19, 2026, titled ""Glenmark Therapeutics Inc., USA launches Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)"".